How Tense Tissue and Immune Cells Drive Scarring

Credibility

Interest

Share:2 min read

Key Takeaway

Stiff, tense tissue can push tendon cells toward scarring, but immune cells can override this and drive more scarring behavior.

What They Found

Researchers built a lab model that stretches tendon-like tissue to mimic the tight, stiff environment seen in systemic sclerosis. When the tissue was kept under higher tension (like a tightened rubber band), tendon support cells called fibroblasts became myofibroblasts — a cell type that makes more scar tissue and stiffens the area. In stiffer, three-dimensional tissue samples, the genes that make main scar-building collagens were actually lower, while genes linked to communication between structural cells and immune cells were higher. When immune cells (macrophages) were added to the stretched tissue, they reversed the drop in collagen gene activity, meaning immune signals can push cells to make more scar even when mechanics would not. Overall, the study shows that both mechanical tension and immune cells act together to control whether tissues heal normally or progress to harmful scarring.

Who Should Care and Why

People with systemic sclerosis or other fibrotic conditions should care because this helps explain why tendons and other tissues can become stiffer and scarred over time — not just from injury but from the physical environment and immune activity. Caregivers and patients can think of tissue mechanics like the tension in a hammock: if it’s too tight, the supports change shape and behave differently, which can lead to lasting damage; immune cells are like someone repeatedly poking the hammock, making the change worse. Healthcare providers and researchers can use this knowledge to think about treatments that relax tissue tension or change immune signals, potentially slowing or preventing scar growth. Physical therapists might consider how mechanical loading (exercise or splints) could affect scarring, so discussing tension and movement with the care team matters. Patients using immunomodulatory treatments should know that immune activity can strongly influence scarring, so medications that change immune behavior could affect tendon and tissue stiffness.

Important Considerations

This study used a lab-built model that imitates some, but not all, features of real human tissue, so results may not fully match what happens in a person. The findings show connections between mechanics and immune signals, but they don’t prove a specific treatment that will work in patients yet. Because human bodies are more complex, any new therapies suggested by this work will need careful testing in clinical trials before patients should expect changes in care.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research Specific Symptoms MS Progression

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Nature communications often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News